Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA059326-06
Application #
6102907
Study Section
Project Start
1998-01-01
Project End
1998-12-31
Budget Start
Budget End
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chen, R L; Reynolds, C P; Seeger, R C (2000) Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating. Cancer Immunol Immunother 48:603-12
Penichet, M L; Challita, P M; Shin, S U et al. (1999) In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci 49:179-88
Kutubuddin, M; Federoff, H J; Challita-Eid, P M et al. (1999) Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors. Blood 93:643-54
Shau, H; Huang, A C; Faris, M et al. (1998) Thioredoxin peroxidase (natural killer enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem Biophys Res Commun 249:683-6
Challita-Eid, P M; Penichet, M L; Shin, S U et al. (1998) A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway. J Immunol 160:3419-26
Challita-Eid, P M; Abboud, C N; Morrison, S L et al. (1998) A RANTES-antibody fusion protein retains antigen specificity and chemokine function. J Immunol 161:3729-36
Shau, H; Kim, A T; Hedrick, C C et al. (1997) Endogenous natural killer enhancing factor-B increases cellular resistance to oxidative stresses. Free Radic Biol Med 22:497-507
Kim, A T; Sarafian, T A; Shau, H (1997) Characterization of antioxidant properties of natural killer-enhancing factor-B and induction of its expression by hydrogen peroxide. Toxicol Appl Pharmacol 147:135-42
Syljuasen, R G; Belldegrun, A; Tso, C L et al. (1997) Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection. Radiat Res 148:443-8
Arthur, J F; Butterfield, L H; Roth, M D et al. (1997) A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther 4:17-25

Showing the most recent 10 out of 31 publications